National Cancer Institute of Kenya

Directions Website

National Cancer Institute of Kenya The National Cancer Institute of Kenya is a statutory body created under the Cancer Prevention and Control Act (No. 15 of 2012).

This was in recognition of the need for a more coordinated health sector response to the growing cancer burden in Kenya

NCI-K at the World Cancer Congress 2026 in Hong KongThe National Cancer Institute of Kenya (NCI-K) is contributing to gl...
25/09/2026

NCI-K at the World Cancer Congress 2026 in Hong Kong
The National Cancer Institute of Kenya (NCI-K) is contributing to global conversations on strengthening cancer control systems at the ongoing World Cancer Congress 2026 in Hong Kong, taking place from 24–26 September. The Congress brings together more than 2,000 cancer researchers, health professionals, policymakers, civil society organisations, advocates and people with lived experience from more than 120 countries.

Emily Barsito, the Head of Strategic Planning, Resource Mobilization and Partnerships at the National Cancer Institute of Kenya chaired the Main Stage Abstract Oral session, themed “Financing and Scaling Cancer Systems in LMICs: Sustainable Models from Policy to Practice.”

The session explored critical issues shaping sustainable cancer care in low- and middle-income countries, including:

• Sequencing breast cancer scale-up and setting national priorities
• Moving from fragmented supply systems towards affordable and quality cancer care
• Policy approaches to cervical cancer elimination and control
• Understanding the relationship between cancer policy and practice
• Financing equitable cancer care in Kenya amid health financing reforms.

The World Cancer Congress provides an important platform for countries to share evidence, experiences and practical approaches towards reducing the global burden of cancer.

HealthSystems CancerFinancing Kenya

NCI-K at the World Cancer Congress 2026 in Hong KongThe National Cancer Institute of Kenya (NCI-K) is contributing to gl...
25/09/2026

NCI-K at the World Cancer Congress 2026 in Hong Kong
The National Cancer Institute of Kenya (NCI-K) is contributing to global conversations on strengthening cancer control systems at the ongoing World Cancer Congress 2026 in Hong Kong, taking place from 24–26 September. The Congress brings together more than 2,000 cancer researchers, health professionals, policymakers, civil society organisations, advocates and people with lived experience from more than 120 countries.

Emily Barsito, the Head of Strategic Planning, Resource Mobilization and Partnerships at the National Cancer Institute of Kenya chaired the Main Stage Abstract Oral session, themed “Financing and Scaling Cancer Systems in LMICs: Sustainable Models from Policy to Practice.”

The session explored critical issues shaping sustainable cancer care in low- and middle-income countries, including:

• Sequencing breast cancer scale-up and setting national priorities
• Moving from fragmented supply systems towards affordable and quality cancer care
• Policy approaches to cervical cancer elimination and control
• Understanding the relationship between cancer policy and practice
• Financing equitable cancer care in Kenya amid health financing reforms.

The World Cancer Congress provides an important platform for countries to share evidence, experiences and practical approaches towards reducing the global burden of cancer.

World Cancer Research Day | Advancing Cancer Research for a Healthier KenyaThe National Cancer Institute of Kenya (NCI-K...
24/09/2026

World Cancer Research Day | Advancing Cancer Research for a Healthier Kenya

The National Cancer Institute of Kenya (NCI-K) is strengthening cancer research as a critical foundation for better prevention, early detection, treatment, survivorship and cancer control.

Through the NCI-K Fund for Research, 20 cancer research projects have been supported cross 8 universities, including University of Embu, Masinde Muliro University of Science and Technology, Chuka University, University of Nairobi, University of Eastern Africa Baraton, Maseno University, JARAMOGI OGINGA ODINGA UNIVERSITY OF SCIENCE AND TECHNOLOGY (JOOUST), and Strathmore University; research institutions; Kenya Medical Research Institute (KEMRI), Ciheb Kenya, Adaptive Management and Research Consultants (AMREC Africa), counties, including Wajir County and health facilities, Moi Teaching and Referral Hospital, Kenyatta University Teaching, Referral & Research Hospital, Scanlab Research, generating locally relevant evidence to inform healthcare practice, planning and policy. More than 500 applications were received through the two funding calls, demonstrating the growing research capacity and interest in cancer research in Kenya.

The research supported by NCI-K is already producing practical outputs. These include an AI-based breast cancer detection prototype and annotated mammogram dataset, quality systems for molecular testing of childhood leukemia, an antibiogram for opportunistic pathogens in oncology settings, an aflatox
in monitoring and eradication application, a colorectal cancer survivorship guide and care template, and policy and legal analyses on benefit-sharing in cancer research.

The Institute has also strengthened cancer surveillance and data systems. The National Cancer Registry and Dashboard now captures more than 114,000 cancer cases from 83 reporting facilities, while the EMPOWER digital platform supports patient navigation across more than 57 facilities and has reached over 8,000 patients.

Research capacity is also being expanded. Kenya has been designated an IARC-GICR Centre of Expertise for Sub-Saharan Africa, while more than 500 cancer registrars have been trained, including 13 WHO globally certified cancer registrars, with national registrars deployed to support cancer registration across the country.

On this World Cancer Research Day, NCI-K reaffirms its commitment to research that generates evidence, strengthens cancer data, builds national capacity and translates knowledge into action—helping shape a stronger and more responsive cancer control system for Kenya.

Towards a Cancer-Free Nation

The National Cancer Institute of Kenya (NCI-K) Cancer Prevention and Control (CPC) officers, Julius Kibichii, Linet Kosk...
23/09/2026

The National Cancer Institute of Kenya (NCI-K) Cancer Prevention and Control (CPC) officers, Julius Kibichii, Linet Koskei, and Joan Ritho, presented their technical views to the Parliamentary Health Committee on the proposed To***co Control Amendment Bill, contributing to ongoing discussions on strengthening to***co control and protecting public health.

The engagement provided an opportunity to share evidence and perspectives on the health consequences of to***co use, including its established link to several cancers and other non-communicable diseases.

Beyond policy engagement, NCI-K continues to support cancer prevention through public education and community awareness, empowering individuals and communities with knowledge on reducing cancer risk, making healthier choices, and seeking timely screening and care.

To***co control remains an important component of cancer prevention. Through evidence-based advocacy, education, and collaboration with stakeholders, NCI-K continues to support efforts to reduce preventable cancers and advance the national cancer control agenda.

Towards a Cancer-Free Nation.

NCI-K Advances Global Dialogue on Innovative Financing for Cancer Care at UN General AssemblyThe National Cancer Institu...
22/09/2026

NCI-K Advances Global Dialogue on Innovative Financing for Cancer Care at UN General Assembly

The National Cancer Institute of Kenya (NCI-K) participated in the 81st United Nations General Assembly, contributing to global discussions on innovative financing for cancer care and expanding access to essential cancer services.

During the Leaders Health Summit Executive Session, NCI-K CEO Dr. Elias Melly highlighted the need for innovative and blended financing mechanisms to increase investment in cancer prevention, diagnosis and treatment, with a particular focus on women’s cancers.

The discussions explored opportunities to align healthcare, artificial intelligence infrastructure, green energy and sustainable supply chains to establish sustainable financing models that can unlock greater public and private investment in cancer care.

Such investments could support critical interventions including cervical cancer vaccination, cancer screening, AI-enhanced diagnosis and treatment, alongside other priorities in cancer prevention and control.

The engagement brought together representatives from private equity, sovereign wealth institutions, technology companies, philanthropic organisations and other global partners, highlighting the importance of strategic partnerships in mobilising resources for stronger and more sustainable cancer control systems.

NCI-K remains committed to advancing partnerships and innovative financing solutions that expand access to quality cancer services and improve outcomes for patients in Kenya.

Towards a Cancer-Free Nation.

INVITATION: CHILDHOOD CANCER AWARENESS TALK The Lions Club of Kericho invites you to a virtual conversation on childhood...
21/09/2026

INVITATION: CHILDHOOD CANCER AWARENESS TALK

The Lions Club of Kericho invites you to a virtual conversation on childhood cancer awareness, bringing together experts to share knowledge on early detection, prevention, support and the importance of timely care.

We are honoured to have Dr. Timothy Olweny, Chairperson, Board of Trustees, National Cancer Institute of Kenya, and Dr. Nashat Fadhloon Noor, Clinical Oncologist and Director, Cancer Prevention & Control, National Cancer Institute of Kenya, as the guests.

📅 Wednesday, 23rd September 2026
⏰ 7:30 PM – 8:30 PM
💻 Virtual/Online

Join us as we learn, share, and stand together for healthier, brighter futures for our children.

🔗 Join the conversation using the link below:
https://us02web.zoom.us/meeting/register/X4hvWo4ERsiMwSJ73eEWzQ

Together for Healthier Children.
Early Detection Saves Lives.

Prostate cancer can be detected early, and early detection can make a significant difference in treatment outcomes.Men a...
21/09/2026

Prostate cancer can be detected early, and early detection can make a significant difference in treatment outcomes.

Men are encouraged to talk to a healthcare provider about prostate cancer screening, especially those at higher risk, including men aged 50 and above and those with a family history of prostate cancer.

Don’t wait for symptoms. Know your risk. Get screened.

Early detection can provide more treatment options and better chances of successful management.

Towards a Cancer-free Nation.

Every child facing cancer deserves access to timely, quality care and the opportunity to live a healthy and fulfilling l...
15/09/2026

Every child facing cancer deserves access to timely, quality care and the opportunity to live a healthy and fulfilling life.
As 𝑁𝐶𝐼-𝐾, we remain committed to strengthening childhood cancer prevention, early detection, diagnosis and treatment, while ensuring that children and their families receive the support they need throughout the cancer care journey.
ChildhoodCancer

NCI-K Strengthens Partnership with Roche to Advance Cancer Prevention and ControlToday, the National Cancer Institute of...
14/09/2026

NCI-K Strengthens Partnership with Roche to Advance Cancer Prevention and Control
Today, the National Cancer Institute of Kenya (NCI-K) CEO held a meeting with Ms. Jacky Wambua, General Manager, Eastern Africa, Roche Pharmaceutical Company, a Switzerland-based global healthcare innovator with a long-standing commitment to advancing cancer care through innovative medicines, diagnostics and personalized healthcare.
The meeting focused on strengthening strategic partnerships across the entire cancer care continuum, from prevention and early detection to diagnosis, treatment, research, and survivorship, to address the growing burden of cancer in Kenya and beyond.
Key areas of discussion included:
1. Cancer screening and early detection – Exploring opportunities to strengthen cancer screening and linkage to care, including leveraging the Empower 2.0 platform, which has enhanced screening and linkage to appropriate care.
2. Strengthening Centres of Excellence – Expanding and leveraging existing Centres of Excellence for cancer diagnosis through Roche-supported capacity building, particularly in breast and cervical cancer diagnosis.
3. Access to cancer treatment – Acknowledging the Herceptin Access Programme and exploring opportunities to onboard additional innovative cancer medicines into access programmes, alongside opportunities to optimise the Cancer Benefits Package under the Social Health Authority (SHA).
4. Research, development and local manufacturing – Exploring opportunities to strengthen cancer research and development, promote linkages with local manufacturing and contribute to national development.
5. Strengthening cancer health systems – Building stronger cancer health systems across all health-system building blocks and advancing integration of cancer prevention and control into Universal Health Coverage (UHC).

Roche's longstanding work in oncology, including the development of innovative cancer medicines and diagnostic technologies, aligns with the need for stronger partnerships to improve cancer prevention, diagnosis and treatment.

NCI-K embraces strategic partnerships and innovation as key investments in Kenya's cancer ecosystem, bringing together government, industry, researchers and other stakeholders to improve cancer outcomes and move the country closer to a cancer-free nation.

Towards a Cancer-Free Nation.

Men, take charge of your health. Go for prostate cancer screening.Prostate cancer may not cause symptoms in its early st...
11/09/2026

Men, take charge of your health. Go for prostate cancer screening.

Prostate cancer may not cause symptoms in its early stages. Early detection can improve treatment and outcomes.

Men, especially those at increased risk, are encouraged to talk to a healthcare provider about their risk and whether prostate cancer screening is appropriate for them.

Don’t wait for symptoms. Know your risk. Get screened. Seek medical attention early.

Towards a Cancer-Free Nation

Address

P. O. Box 27437
Nairobi
00100

Opening Hours

Monday 08:00 - 17:00
Tuesday 08:00 - 17:00
Wednesday 08:00 - 17:00
Thursday 08:00 - 17:00
Friday 08:00 - 17:00

Website

Alerts

Be the first to know and let us send you an email when National Cancer Institute of Kenya posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category